Table 3.
Summary of methodological quality assessment scores.
| References | Oliver and Brezzo (2009) | Tomljanović et al. (2011) | Sander et al. (2013) | Elbadry (2014) | Cherepov and Shaikhetdinov (2016) | Alonso-Fernández et al. (2017) | Yildiz et al. (2019) | Baron et al. (2020) | Keiner et al. (2020) |
|---|---|---|---|---|---|---|---|---|---|
| Eligibility criteria | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Random allocation | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 0 | 0 |
| Allocation concealment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group similar at baseline | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Blind therapist | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Blind assessor | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Follow-up | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intention to treat analysis | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Between group comparisons | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Point measure and variability | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| PEDro score | 4 | 4 | 3 | 3 | 3 | 4 | 4 | 3 | 3 |